Maclizumab Dexamethasone - a CD163 Targeting Antibody Drug Conjugate directed Macrophages for Treatment of NASH and AAH
The novel ADC inhibits NASH progression in terms of ballooning, fat accumulation and fibrosis
- Intellectual property rights are hold by three patent families (WO2011039510, WO2011039511, WO2002032941).
- Patent application submitted
- Development partner
- Commercial partner
- Seeking investment